Besides, Zhong et al. [100] reported that TREM2 suppressed the activation of classical complement cascade and complement-mediated synaptic loss in AD mice models by directly binding to C1q, the initiator of the classical complement pathway. Here, TREM2 is linked to Alzheimer disease.